Pulmonary embolism: Difference between revisions

	Pulmonary Embolism Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Pulmonary Embolism from other Diseases
Epidemiology and Demographics
Risk Factors
Triggers
Natural History, Complications and Prognosis
Diagnosis
Diagnostic criteria
Assessment of Clinical Probability and Risk Scores
Pulmonary Embolism Assessment of Probability of Subsequent VTE and Risk Scores
History and Symptoms
Physical Examination
Laboratory Findings
Arterial Blood Gas Analysis
D-dimer
Biomarkers
Electrocardiogram
Chest X Ray
Ventilation/Perfusion Scan
Echocardiography
Compression Ultrasonography
CT
MRI
Treatment
Treatment approach
Medical Therapy
IVC Filter
Pulmonary Embolectomy
Pulmonary Thromboendarterectomy
Discharge Care and Long Term Treatment
Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Follow-Up
Support group
Special Scenario
Pregnancy
Cancer
Trials
Landmark Trials
Case Studies
Case #1
Pulmonary embolism On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Pulmonary embolism
CDC on Pulmonary embolism
Pulmonary embolism in the news
Blogs on Pulmonary embolism
Directions to Hospitals Treating Pulmonary embolism
Risk calculators and risk factors for Pulmonary embolism

Revision as of 16:03, 4 February 2013

For patient information, click here

Editor(s)-In-Chief: C. Michael Gibson, M.S., M.D. [1], The APEX Trial Investigators; Associate Editor(s)-in-Chief: Cafer Zorkun, M.D., Ph.D. [2]

Synonyms and keywords: PE; lung blood clot; blood clot-lung; embolism-pulmonary

Diagnosis: Suspected high-risk PE| Suspected non-high-risk PE | Low clinical probability | Intermediate clinical probability | High clinical probability

Treatment: High-risk pulmonary embolism | Non-high-risk pulmonary embolism | Long-term treatment | Inferior vena cava filters

@@ Line 41: / Line 41: @@
 ==Guidelines==
-===ACC/AHA Guidelines===
-[[Pulmonary embolism medical therapy#ACC/AHA 2011 Guidelines- Recommendations for Initial Anticoagulation for Acute PE (DO NOT EDIT)| Guidelines for Initial Anticoagulation for Acute PE]]
-| [[Pulmonary embolism surgery#ACC/AHA 2011 Guidelines- Recommendations for Catheter Embolectomy and Fragmentation (DO NOT EDIT)|Surgical embolectomy]]
-| [[Pulmonary_embolism_surgery#ACC/AHA 2011 Guidelines- Recommendations on IVC Filters in the Setting of Acute PE (DO NOT EDIT)|Inferior vena cava filters]]
-| [[Pulmonary_embolism_surgery#ACC/AHA 2011 Guidelines-Recommendations for Endovascular Thrombolysis and Surgical Venous Thrombectomy (DO NOT EDIT)|Thromboreductive Strategies]]
-| [[Pulmonary_embolism_surgery#ACC/AHA 2011 Guidelines- Recommendations for Percutaneous Transluminal Venous Angioplasty and Stenting (DO NOT EDIT)|Percutaneous Transluminal Venous Angioplasty and Stent Placement]]
 ===ESC Guidelines===